NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) biotechnology company, will present at the 12th Annual BIO CEO & Investor Conference tomorrow, Tuesday, February 9, 2010 at 3:00 PM EST.
